133 related articles for article (PubMed ID: 9875778)
1. Isolated lung perfusion with melphalan and tumor necrosis factor for metastatic pulmonary adenocarcinoma.
Hendriks JM; Van Schil PE; De Boeck G; Lauwers PR; Van Oosterom AA; Van Marck EA; Eyskens EJ
Ann Thorac Surg; 1998 Nov; 66(5):1719-25. PubMed ID: 9875778
[TBL] [Abstract][Full Text] [Related]
2. Isolated lung perfusion with melphalan for the treatment of metastatic pulmonary sarcoma.
Nawata S; Abecasis N; Ross HM; Abolhoda A; Cheng H; Sachar KS; Burt ME
J Thorac Cardiovasc Surg; 1996 Dec; 112(6):1542-7; discussion 1547-8. PubMed ID: 8975846
[TBL] [Abstract][Full Text] [Related]
3. Selective pulmonary artery perfusion with melphalan is equal to isolated lung perfusion but superior to intravenous melphalan for the treatment of sarcoma lung metastases in a rodent model.
Den Hengst WA; Hendriks JM; Van Hoof T; Heytens K; Guetens G; de Boeck G; Lardon F; Van Schil PE
Eur J Cardiothorac Surg; 2012 Aug; 42(2):341-7; discussion 347. PubMed ID: 22345285
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with gemcitabine with isolated lung perfusion for the treatment of pulmonary metastases.
Van Putte BP; Hendriks JM; Romijn S; Pauwels B; Vermorken JB; Van Schil PE
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):125-30. PubMed ID: 15999051
[TBL] [Abstract][Full Text] [Related]
5. Isolated lung perfusion for the treatment of pulmonary metastases an experimental study in the rat.
Van Schil P; Hendriks J
Verh K Acad Geneeskd Belg; 1999; 61(4):517-50. PubMed ID: 10500475
[TBL] [Abstract][Full Text] [Related]
6. Isolated lung perfusion with melphalan prolongs survival in a rat model of metastatic pulmonary adenocarcinoma.
Hendriks JM; Van Schil PE; Van Oosterom AA; Kuppen PJ; Van Marck E; Eyskens E
Eur Surg Res; 1999; 31(3):267-71. PubMed ID: 10352355
[TBL] [Abstract][Full Text] [Related]
7. Single-pass isolated lung perfusion versus recirculating isolated lung perfusion with melphalan in a rat model.
Van Putte BP; Hendriks JM; Romijn S; Guetens G; De Boeck G; De Bruijn EA; Van Schil PE
Ann Thorac Surg; 2002 Sep; 74(3):893-8; discussion 898. PubMed ID: 12238857
[TBL] [Abstract][Full Text] [Related]
8. Isolated lung perfusion with melphalan: pharmacokinetics and toxicity in a pig model.
van der Elst A; Oosterling SJ; Paul MA; Vonk AM; Sparidans RW; van der Sijp JR
J Surg Oncol; 2006 Apr; 93(5):410-6. PubMed ID: 16550578
[TBL] [Abstract][Full Text] [Related]
9. In vivo isolated kidney perfusion with tumour necrosis factor alpha (TNF-alpha) in tumour-bearing rats.
van der Veen AH; Seynhaeve AL; Breurs J; Nooijen PT; Marquet RL; Eggermont AM
Br J Cancer; 1999 Feb; 79(3-4):433-9. PubMed ID: 10027309
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of isolated lung perfusion with melphalan for resectable pulmonary metastases, a phase I and extension trial.
Grootenboers MJ; Hendriks JM; van Boven WJ; Knibbe CA; van Putte B; Stockman B; De Bruijn E; Vermorken JB; Van Schil PE; Schramel FM
J Surg Oncol; 2007 Dec; 96(7):583-9. PubMed ID: 17999399
[TBL] [Abstract][Full Text] [Related]
11. [Isolated hyperthermic limb perfusion with melphalan and tumor necrosis factor in malignant melanoma].
Kettelhack C; Hohenberger P; Schlag PM
Dtsch Med Wochenschr; 1997 Feb; 122(7):177-81. PubMed ID: 9072487
[TBL] [Abstract][Full Text] [Related]
12. Regional differences of melphalan lung levels after isolated lung perfusion in the rat.
Romijn S; Hendriks JM; Van Putte BP; Weyler J; Guetens G; De Boeck G; Van Schil PE
J Surg Res; 2005 May; 125(2):157-60. PubMed ID: 15854668
[TBL] [Abstract][Full Text] [Related]
13. Early destruction of tumor vasculature in tumor necrosis factor-alpha-based isolated limb perfusion is responsible for tumor response.
Hoving S; Seynhaeve AL; van Tiel ST; aan de Wiel-Ambagtsheer G; de Bruijn EA; Eggermont AM; ten Hagen TL
Anticancer Drugs; 2006 Sep; 17(8):949-59. PubMed ID: 16940805
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study.
Nooijen PT; Manusama ER; Eggermont AM; Schalkwijk L; Stavast J; Marquet RL; de Waal RM; Ruiter DJ
Br J Cancer; 1996 Dec; 74(12):1908-15. PubMed ID: 8980389
[TBL] [Abstract][Full Text] [Related]
15. High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation.
Gutman M; Inbar M; Lev-Shlush D; Abu-Abid S; Mozes M; Chaitchik S; Meller I; Klausner JM
Cancer; 1997 Mar; 79(6):1129-37. PubMed ID: 9070490
[TBL] [Abstract][Full Text] [Related]
16. Anterograde versus retrograde isolated lung perfusion with melphalan in the WAG-Rij rat.
Romijn S; Hendriks JM; Van Putte BP; Weyler J; Guetens G; De Boeck G G; De Bruijn EA; Van Schil PE
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1083-5. PubMed ID: 15896622
[TBL] [Abstract][Full Text] [Related]
17. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.
Alexander HR; Libutti SK; Bartlett DL; Puhlmann M; Fraker DL; Bachenheimer LC
Clin Cancer Res; 2000 Aug; 6(8):3062-70. PubMed ID: 10955785
[TBL] [Abstract][Full Text] [Related]
18. [Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor].
Kettelhack C; Hohenberger P; Schlag PM
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():127-9. PubMed ID: 9101810
[TBL] [Abstract][Full Text] [Related]
19. Variations in flow, duration, and concentration do not change the final lung concentration of melphalan after isolated lung perfusion in rats.
Romijn S; Hendriks JM; Van Putte BP; Guetens G; De Bruijn EA; Van Schil PE
Eur Surg Res; 2003; 35(1):50-3. PubMed ID: 12566788
[TBL] [Abstract][Full Text] [Related]
20. Isolated lung perfusion with melphalan for resectable lung metastases: a phase I clinical trial.
Hendriks JM; Grootenboers MJ; Schramel FM; van Boven WJ; Stockman B; Seldenrijk CA; ten Broecke P; Knibbe CA; Slee P; De Bruijn E; Vlaeminck R; Heeren J; Vermorken JB; van Putte B; Romijn S; Van Marck E; Van Schil PE
Ann Thorac Surg; 2004 Dec; 78(6):1919-26; discussion 1926-7. PubMed ID: 15561001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]